Acute Ischemic Stroke Clinical Trials in Wuhan, Hubei
7 recruitingWuhan, Hubei, China
Showing 1–7 of 7 trials
Recruiting
Phase 2
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Acute Ischemic Stroke
Shanghai Pharmaceuticals Holding Co., Ltd300 enrolled28 locationsNCT05686642
Recruiting
Phase 2Phase 3
Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke
Acute Ischemic Stroke
Xiang Luo429 enrolled2 locationsNCT06696820
Recruiting
Phase 2Phase 3
Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion
Acute Ischemic StrokeMedium Vessel Occlusion
Xiang Luo382 enrolled1 locationNCT07302854
Recruiting
Not Applicable
Angong Niuhuang Pills With Different Bovine Bezoar Formulation Sources in the Treatment of AIS
Acute Ischemic Stroke
Tongji Hospital100 enrolled1 locationNCT06883110
Recruiting
Phase 3
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2
Acute Ischemic Stroke
Capital Medical University692 enrolled22 locationsNCT07263776
Recruiting
Phase 3
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT）
Acute Ischemic StrokeAnterior Circulation Brain Infarction
Capital Medical University2,105 enrolled56 locationsNCT06559241
Recruiting
Not Applicable
Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD)
Acute Ischemic StrokeIschemic Cerebrovascular DiseaseCerebral Small Vessel Diseases
Tongji Hospital230 enrolled2 locationsNCT06474507